These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29748581)

  • 1. Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation.
    Yang F; Wu R; Jiang Z; Chen J; Nan J; Su S; Zhang N; Wang C; Zhao J; Ni C; Wang Y; Hu W; Zeng Z; Zhu K; Liu X; Hu X; Zhu W; Yu H; Huang J; Wang J
    Cell Death Dis; 2018 May; 9(5):556. PubMed ID: 29748581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin enhances glycolysis via OPA1-mediated mitochondrial fusion to promote mesenchymal stem cell survival.
    Yang F; Li B; Yang Y; Huang M; Liu X; Zhang Y; Liu H; Zhang L; Pan Y; Tian S; Wu Y; Wang L; Yang L
    Int J Mol Med; 2019 Jul; 44(1):301-312. PubMed ID: 31115489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L-mediated OPA1 processing.
    Zhao Y; Zhu J; Zhang N; Liu Q; Wang Y; Hu X; Chen J; Zhu W; Yu H
    Stem Cells Transl Med; 2020 Oct; 9(10):1257-1271. PubMed ID: 32515551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial membrane potential and oxidative stress interact to regulate Oma1-dependent processing of Opa1 and mitochondrial dynamics.
    Fogo GM; Raghunayakula S; Emaus KJ; Torres Torres FJ; Wider JM; Sanderson TH
    FASEB J; 2024 Sep; 38(18):e70066. PubMed ID: 39312414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission.
    Anand R; Wai T; Baker MJ; Kladt N; Schauss AC; Rugarli E; Langer T
    J Cell Biol; 2014 Mar; 204(6):919-29. PubMed ID: 24616225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury.
    Xiao X; Hu Y; Quirós PM; Wei Q; López-Otín C; Dong Z
    Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1318-26. PubMed ID: 24671334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1.
    Ehses S; Raschke I; Mancuso G; Bernacchia A; Geimer S; Tondera D; Martinou JC; Westermann B; Rugarli EI; Langer T
    J Cell Biol; 2009 Dec; 187(7):1023-36. PubMed ID: 20038678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation.
    MacVicar TD; Lane JD
    J Cell Sci; 2014 May; 127(Pt 10):2313-25. PubMed ID: 24634514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohibitin levels regulate OMA1 activity and turnover in neurons.
    Anderson CJ; Kahl A; Fruitman H; Qian L; Zhou P; Manfredi G; Iadecola C
    Cell Death Differ; 2020 Jun; 27(6):1896-1906. PubMed ID: 31819158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane depolarization activates the mitochondrial protease OMA1 by stimulating self-cleavage.
    Zhang K; Li H; Song Z
    EMBO Rep; 2014 May; 15(5):576-85. PubMed ID: 24719224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers.
    Kong B; Wang Q; Fung E; Xue K; Tsang BK
    J Biol Chem; 2014 Sep; 289(39):27134-27145. PubMed ID: 25112877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-induced OMA1 activation and autocatalytic turnover regulate OPA1-dependent mitochondrial dynamics.
    Baker MJ; Lampe PA; Stojanovski D; Korwitz A; Anand R; Tatsuta T; Langer T
    EMBO J; 2014 Mar; 33(6):578-93. PubMed ID: 24550258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria.
    Korwitz A; Merkwirth C; Richter-Dennerlein R; Tröder SE; Sprenger HG; Quirós PM; López-Otín C; Rugarli EI; Langer T
    J Cell Biol; 2016 Jan; 212(2):157-66. PubMed ID: 26783299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted OMA1 therapies for cancer.
    Alavi MV
    Int J Cancer; 2019 Nov; 145(9):2330-2341. PubMed ID: 30714136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial OPA1 cleavage is reversibly activated by differentiation of H9c2 cardiomyoblasts.
    Garcia I; Calderon F; la Torre P; Vallier SS; Rodriguez C; Agarwala D; Keniry M; Innis-Whitehouse W; Gilkerson R
    Mitochondrion; 2021 Mar; 57():88-96. PubMed ID: 33383158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells.
    Head B; Griparic L; Amiri M; Gandre-Babbe S; van der Bliek AM
    J Cell Biol; 2009 Dec; 187(7):959-66. PubMed ID: 20038677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.
    Zeng Z; Yu K; Hu W; Cheng S; Gao C; Liu F; Chen J; Kong M; Zhang F; Liu X; Wang J
    Stem Cells Dev; 2021 Apr; 30(7):386-398. PubMed ID: 33567991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress.
    Lee H; Smith SB; Sheu SS; Yoon Y
    J Biol Chem; 2020 May; 295(19):6543-6560. PubMed ID: 32245890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative insults disrupt OPA1-mediated mitochondrial dynamics in cultured mammalian cells.
    Garcia I; Innis-Whitehouse W; Lopez A; Keniry M; Gilkerson R
    Redox Rep; 2018 Dec; 23(1):160-167. PubMed ID: 29961397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitochondrial protease OMA1 acts as a metabolic safeguard upon nuclear DNA damage.
    Rivera-Mejías P; Narbona-Pérez ÁJ; Hasberg L; Kroczek L; Bahat A; Lawo S; Folz-Donahue K; Schumacher AL; Ahola S; Mayer FC; Giavalisco P; Nolte H; Lavandero S; Langer T
    Cell Rep; 2023 Apr; 42(4):112332. PubMed ID: 37002921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.